###### Strengths and limitations of this study

-   This observational study evaluates all patient information leaflets (PILs) of intranasal corticosteroid sprays (INCS) available for patients in the UK.

-   This is the first study that evaluates PILs of INCS on uniformity and completeness.

-   All PILs are collected from the British National Formulary and Medicines and Healthcare products Regulatory Agency websites and each PIL is checked whether a specific instruction for use of the INCS is included.

-   We do not know if administration of INCS depends on the instruction described in PILs.

-   We did not collect data on instructions for the use of INCS given by doctors, nurses and pharmacists and whether the PILs are used during these instructions.

Introduction {#s1}
============

Allergic rhinitis (AR) is a common condition in both children and adults, with prevalences ranging from 9% in children aged 6--7 years and 27% in adults aged 22--44 years.[@R1] The recommended pharmacological treatment of AR includes antihistamines and intranasal corticosteroids. Antihistamines are used in oral and intranasal dosage forms. Corticosteroids suppress inflammation and are available in oral dosage forms, but due to systemic adverse events (AEs), intranasal corticosteroids are preferred.[@R3] Intranasal corticosteroids are available in sprays or drops and in most patients sprays are prescribed. An adequate technique of using intranasal corticosteroid sprays (INCS) is imperative: the technique may affect efficacy, AEs and compliance.[@R5] Little data are available on the association between the quality of the techniques of using INCS and its safety and efficacy.

To our knowledge no standardised protocols are available with instructions for use of INCS. Patient information leaflets (PILs) are the only source of information about instructions, in addition to the instructions given by the doctor, nurse or pharmacist. We explored which instructions for the use of INCS are provided in PILs by the different manufacturers in the UK.

Methods {#s2}
=======

PILs of all INCS of all manufacturers, available for patients in the UK, were collected from the British National Formulary website and the Medicines and Healthcare products Regulatory Agency website. These PILs are identical to what is provided to the patient in the medicine pack. The instructions included in these PILs were categorised in the consecutive steps before, during and after administration of the INCS, as shown in [table 1](#T1){ref-type="table"}. For every PIL we evaluated whether it includes these steps and for each instruction we counted in how many of the PILs it was included. Missing instructions regarding before, during and after administration were coded as such and counted. Steps for priming and cleaning of the sprays are also mentioned in PILs of INCS, which can also be distinguished in consecutive steps. In this analysis, we only exemplify all steps for daily administration of INCS as mentioned in the PILs.

###### 

Instructions for use of the 21 intranasal corticosteroid sprays studied

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Moment                   Step                                                                                    Instruction                                                              Number                                                                                     
  ------------------------ --------------------------------------------------------------------------------------- ------------------------------------------------------------------------ ------------------------------------------------------------------------------------------ ----
  Prior to use             Step 1\                                                                                 Shake the bottle                                                         21                                                                                         
                           Shaking                                                                                                                                                                                                                                                     

  Step 2\                  Take off the dust cap                                                                   21                                                                                                                                                                  
  Take off dust cap                                                                                                                                                                                                                                                                    

  Step 3\                  Blow the nose                                                                           20                                                                                                                                                                  
  Nose blowing                                                                                                                                                                                                                                                                         

  No instruction           1                                                                                                                                                                                                                                                           

  **During use**           Step 4\                                                                                 A                                                                        Forefinger and middle finger on both sides of the nozzle and thumb underneath the bottle   15
                           Hand position                                                                                                                                                                                                                                               

  B                        Hold bottle as shown in the picture                                                     9                                                                                                                                                                   

  Step 5\                  A                                                                                       Put the tip of the nozzle into the nostril and close the other nostril   17                                                                                         
  Closing nostril                                                                                                                                                                                                                                                                      

  B                        Put the tip of the nozzle into the nostril                                              4                                                                                                                                                                   

  Step 6\                  A                                                                                       Slightly tilt forward                                                    18                                                                                         
  Head position                                                                                                                                                                                                                                                                        

  B                        Upright                                                                                 3                                                                                                                                                                   

  Step 7\                  Point the end of the nozzle slightly outwards, away from the centre ridge of the nose   1                                                                                                                                                                   
  Position spray                                                                                                                                                                                                                                                                       

  No instruction           20                                                                                                                                                                                                                                                          

  Step 8\                  A                                                                                       Squirt a spray of mist in the nose while breathing in                    18                                                                                         
  Inhalation instruction                                                                                                                                                                                                                                                               

  B                        Squirt a spray of mist in the nose while breathing in is not necessary                  3                                                                                                                                                                   

  Step 9\                  Breathe out through the mouth.                                                          18                                                                                                                                                                  
  Exhalation instruction                                                                                                                                                                                                                                                               

  No instruction           3                                                                                                                                                                                                                                                           

  **After use**            Step 10\                                                                                A                                                                        Wipe the nozzle with a tissue or handkerchief                                              18
                           Clean nozzle                                                                                                                                                                                                                                                

  B                        Wash the nozzle frequently with warm water.                                             3                                                                                                                                                                   

  Step 11\                 Replace the dust cap                                                                    18                                                                                                                                                                  
  Replace dust cap                                                                                                                                                                                                                                                                     

  No instruction           3                                                                                                                                                                                                                                                           

  Step 12\                 Store the bottle in an upright position.                                                3                                                                                                                                                                   
  Storage                                                                                                                                                                                                                                                                              

  No instruction           18                                                                                                                                                                                                                                                          
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Described are the consecutive steps before, during and after use of INCS, the specific instruction for a step and the number of PILs wherein the specific instruction is described. Daily administration of INCS consists of 12 steps and for some steps different instructions are described.

Patient and public involvement {#s2a}
------------------------------

Patients and public were not directly involved in this study.

Results {#s3}
=======

We identified PILs of INCS from 21 different manufacturers ([table 2](#T2){ref-type="table"}). [Table 1](#T1){ref-type="table"} shows how many PILs include instructions for each step, and [table 2](#T2){ref-type="table"} shows an overview of each spray and whether the instruction is supplied. All PILs instruct to shake the bottle (step 1) and take the dust cap off (step 2) prior to use. Instructions for nose blowing, hand positioning, closing the nostril, head positioning, positioning of the spray, inhaling and exhaling, cleaning the nozzle, replacing the dust cap and storing of the spray (step 3 to step 12) varied or were not included.

###### 

Overview of supplied instructions

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
       Working compound and dosage       Brand name                 Manufacturer           Number\                                        Steps                                                               
                                                                                           of different marketing authorisation holders                                                                       
  ---- --------------------------------- -------------------------- ---------------------- ---------------------------------------------- ------- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
  1    Beclomethasone 50 µg              \-                         Mylan                  16                                             ✓       ✓   ✓   ✓   ✓   ✓       ✓           ✓       ✓       ✓       

  2    Beclomethasone 50 µg              Beconase                   Omega                  \-                                             ✓       ✓   ✓   ✓       ✓       ✓           ✓       ✓   ✓       ✓   

  3    Beclomethasone 50 µg              Beconase                   GSK                    \-                                             ✓       ✓   ✓   ✓       ✓       ✓           ✓       ✓   ✓       ✓   

  4    Beclomethasone 50 µg              Nasobec                    Teva                   \-                                             ✓       ✓   ✓   ✓       ✓       ✓           ✓       ✓   ✓       ✓   

  5    Beclomethasone 50 µg              Hayfever relief            Ayrton Saunders        9                                              ✓       ✓   ✓   ✓       ✓       ✓           ✓       ✓       ✓       

  6    Beclomethasone 50 µg              Pollenase                  Ayrton Saunders        \-                                             ✓       ✓   ✓   ✓       ✓       ✓           ✓       ✓       ✓       

  7    Beclomethasone 50 µg              \-                         Ennogen Pharma         \-                                             ✓       ✓       ✓       ✓       ✓           ✓       ✓   ✓       ✓   

  8    Budesonide 64 µg                  \-                         Sandoz                 4                                              ✓       ✓   ✓       ✓       ✓       ✓           ✓       ✓       ✓   ✓

  9    Budesonide 64 µg                  Rhinocort                  Astrazeneca            4                                              ✓       ✓   ✓       ✓       ✓       ✓           ✓       ✓       ✓   ✓

  10   Budesonide 64 µg                  Benacort                   Astrazeneca            \-                                             ✓       ✓   ✓       ✓       ✓       ✓           ✓       ✓       ✓   ✓

  11   Fluticasone furoate 50 µg         Pirinase hayfever relief   GSK                    \-                                             ✓       ✓   ✓   ✓   ✓   ✓       ✓           ✓       ✓   ✓       ✓   

  12   Fluticasone furoate 50 µg         Hayfever and allergy       GSK                    \-                                             ✓       ✓   ✓   ✓       ✓       ✓           ✓       ✓   ✓       ✓   

  13   Fluticasone furoate 50 µg         Flixonase                  GSK                    7                                              ✓       ✓   ✓   ✓   ✓   ✓       ✓           ✓       ✓   ✓       ✓   

  14   Fluticasone furoate 50 µg         Nasofan                    Teva                   11                                             ✓       ✓   ✓   ✓       ✓       ✓           ✓       ✓   ✓       ✓   

  15   Fluticasone furoate 50 µg         Flunase                    Teva                   \-                                             ✓       ✓   ✓   ✓       ✓       ✓           ✓       ✓   ✓       ✓   

  16   Azelastine 125 µg\                Dymista                    Meda Pharma            \-                                             ✓       ✓   ✓       ✓   ✓       ✓           ✓       ✓   ✓       ✓   
       Fluticasone propionate 50 µg                                                                                                                                                                           

  17   Fluticasone proprionate 27.5 µg   Avamys                     GSK                    \-                                             ✓       ✓   ✓       ✓       ✓   ✓       ✓   ✓       ✓   ✓       ✓   

  18   Mometasone furoate 50 µg          \-                         Teva                   \-                                             ✓       ✓   ✓   ✓       ✓       ✓           ✓       ✓   ✓       ✓   

  19   Mometasone furoate 50 µg          \-                         Sandoz                 \-                                             ✓       ✓   ✓   ✓       ✓       ✓           ✓       ✓   ✓       ✓   

  20   Mometasone furoate 50 µg          \-                         Schering-Plough Labo   10                                             ✓       ✓   ✓   ✓       ✓       ✓           ✓       ✓   ✓       ✓   

  21   Mometasone furoate 50 µg          \-                         Cipla                  \-                                             ✓       ✓   ✓       ✓   ✓       ✓           ✓       ✓   ✓       ✓   
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Listed are the included INCS. Indicated is the working compound and dosage, the brand name if present, the manufacturer and the number of marketing authorisation holders if present. Also, illustrated is an overview of the consecutive steps for use of INCS as described in [table 1](#T1){ref-type="table"}. For each spray is indicated whether a specific step is supplied in the PIL, if supplied than the box is ticked with ✓.

In all 21 PILs one or more steps were missing. Instructions for nose blowing, positioning of the spray, exhaling, replacing the dust cap and storing were missing from 1, 20, 3, 3 and 18 PILs, respectively. Instructions regarding hand positioning, closing the nostril, head positioning, inhaling and cleaning were conflicting across PILs (see [table 1](#T1){ref-type="table"}).

Discussion {#s4}
==========

This study shows that there is a large variation in the PIL instructions for the technique of using INCS across PILs of those sprays available for UK patients.

There has been little research on consistency and impact of instructions for use of INCS given by the doctor, nurse or pharmacist on patients' use of these sprays and their clinical effectiveness. Nor has there been research on the role of PILs on these outcomes.

PILs fulfil a supporting role; information in PILs improve patients' knowledge, but information needs to concise and precise and information needs to be accompanied by oral information.[@R6] Different or missing instructions in PILs for the same product of different manufacturers can confuse the patient and healthcare professionals. Instructions for correct use of INCS is a joined task of doctor, nurse, pharmacist and manufacturer. We believe it is essential to provide uniform and complete instructions in PILs.

Benninger *et al* reviewed the literature on techniques of intranasal steroids and their efficacy and developed detailed instructions for administration of INCS, in order to reach highest efficacy and prevent side effects.[@R7] They recommend to administer the nasal spray in a neutral head position, so to minimise spillage of the drug into the throat which may cause mucosal irritation and facilitate absorption of the drug via the gastrointestinal tract. To minimise the risk of epistaxis, a known AE of INCS, it is recommended to point the nozzle of the spray outward, away from the nasal septum.[@R8]

The set of instructions of Benninger *et al* provides a good basis for the development of uniform and complete instructions for the use of INCS.

A limitation of our study is that we did not collect data on instructions for the use of INCS given by doctors, nurses and pharmacists and whether the PILs are used as a guide during these instructions.

Furthermore, intranasal corticosteroids are also available in nasal drops. The instructions for administration of these intranasal corticosteroid drops differ from the instructions for administration of INCS and are therefore not included in this study.

In conclusion, complete and uniform instructions for the use of INCS are lacking in PILs for registered preparations in the UK. Patients sometimes have to change their INCS due to price differences, stock availability and, sometimes, efficacy. It is confusing that INCS have a completely different set of instruction. Structured and standardised instructions to be used by both professionals and patients are essential in order to optimise daily use of INCS in patients with AR.
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